Milestone Pharmaceuticals Inc. (MIST) Tops Q3 EPS by 4c

Milestone Pharmaceuticals Inc. (NASDAQ: MIST) reported Q3 EPS of ($0.12), $0.04 better than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Milestone Pharmaceuticals Inc. (MIST) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• MGM Resorts (MGM) PT Raised to $55 at Argus
• DA Davidson Reiterates Buy Rating on Boost Run (BRUN)